focus -WSS

focus

author：fashion 2025-10-02 13:13:45 - browse：5518

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Solving academic medical centers' existential crisis

WSS

Solving academic medical centers' existential crisis

AstraZeneca bets AAV gene therapy will still deliver the goods

Arc Institute generative AI designs new CRISPR systems

Venture capitalist Bob Kocher on the state of digital health

Helping hospitals and community health centers plan for resilience

Anxious about a speech? A startup wants you to pop a minty cardiac drug

hotspot

focus

knowledge

How one medical school became remarkably diverse

Criminal prosecution for violating HIPAA: an emerging threat

Moonlake's readout produced a cash windfall. Risks remain

Venture capitalist Bob Kocher on the state of digital health

Sports medicine is finally prioritizing gender equality

Helping hospitals and community health centers plan for resilience

Medical records are filled with copy

FDA panel gives mixed vote on blood pressure devices

In age of alternative facts, a scholarly course on calling out crap

Study finds new variant for Parkinson’s in African populations

entertainment

2024 GOP presidential candidates spar over abortion in debate

How a symptom of dementia informs our understanding of creativity

Second House panel advances two

Helping hospitals and community health centers plan for resilience

Feds fine Medicare Advantage plans for overcharging members

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

knowledge

leisure time

hotspot

entertainment